Brief: Esperion Therapeutics Q1 Basic EPS USD -0.21
06/05/2025 11:00
May 06 (Reuters) - Esperion Therapeutics Q1 product sales USD 34.913 million. Q1 operating expenses USD 87.091 million Q1 operating income USD -22.096 million Q1 net income USD -40.455 million
Recent news on Esperion Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi